Active Ingredient: MESALAMINE
Proprietary Name: LIALDA
Dosage Form; Route of Administration: TABLET, DELAYED RELEASE; ORAL
Strength: 1.2GM
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N022000
Product Number: 001
Approval Date: Jan 16, 2007
Applicant Holder Full Name: TAKEDA PHARMACEUTICALS USA INC
Marketing Status:
Prescription
Patent and Exclusivity Information